DCTs completely revise historical trial processes by executing trials through telemedicine and mobile or local health care providers. Although COVID increased the need for DCTs, 75% of the industry report very little use of decentralized and virtual trials. Read more from Dario Lirio, Senior Director, LifeSphere Clinical, over on PharmaLive.
